Literature DB >> 24764453

Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic properties.

Bernd Uhl1, Gabriele Zuchtriegel1, Daniel Puhr-Westerheide1, Marc Praetner1, Markus Rehberg1, Matthias Fabritius1, Maximilian Hessenauer1, Martin Holzer1, Andrej Khandoga1, Robert Fürst1, Stefan Zahler1, Fritz Krombach1, Christoph A Reichel2.   

Abstract

OBJECTIVE: Neutrophil infiltration of the postischemic tissue considerably contributes to organ dysfunction on ischemia/reperfusion injury. Beyond its established role in fibrinolysis, tissue-type plasminogen activator (tPA) has recently been implicated in nonfibrinolytic processes. The role of this serine protease in the recruitment process of neutrophils remains largely obscure. APPROACH AND
RESULTS: Using in vivo microscopy on the postischemic cremaster muscle, neutrophil recruitment and microvascular leakage, but not fibrinogen deposition at the vessel wall, were significantly diminished in tPA(-/-) mice. Using cell transfer techniques, leukocyte and nonleukocyte tPA were found to mediate ischemia/reperfusion-elicited neutrophil responses. Intrascrotal but not intra-arterial application of recombinant tPA induced a dose-dependent increase in the recruitment of neutrophils, which was significantly higher compared with stimulation with a tPA mutant lacking catalytic activity. Whereas tPA-dependent transmigration of neutrophils was selectively reduced on the inhibition of plasmin or gelatinases, neutrophil intravascular adherence was significantly diminished on the blockade of mast cell activation or lipid mediator synthesis. Moreover, stimulation with tPA caused a significant elevation in the leakage of fluorescein isothiocyanate dextran to the perivascular tissue, which was completely abolished on neutrophil depletion. In vitro, tPA-elicited macromolecular leakage of endothelial cell layers was abrogated on the inhibition of its proteolytic activity.
CONCLUSIONS: Endogenously released tPA promotes neutrophil transmigration to reperfused tissue via proteolytic activation of plasmin and gelatinases. As a consequence, tPA on transmigrating neutrophils disrupts endothelial junctions allowing circulating tPA to extravasate to the perivascular tissue, which, in turn, amplifies neutrophil recruitment through the activation of mast cells and release of lipid mediators.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  fibrinolysis; inflammation; leukocytes; microvascular permeability; neutrophils; reperfusion injury; tissue plasminogen activator

Mesh:

Substances:

Year:  2014        PMID: 24764453     DOI: 10.1161/ATVBAHA.114.303721

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

Review 1.  The role of tissue resident cells in neutrophil recruitment.

Authors:  Nancy D Kim; Andrew D Luster
Journal:  Trends Immunol       Date:  2015-08-18       Impact factor: 16.687

Review 2.  Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.

Authors:  Bernhard F Becker; Matthias Jacob; Stephanie Leipert; Andrew H J Salmon; Daniel Chappell
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

3.  uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils.

Authors:  Bernd Uhl; Laura A Mittmann; Julian Dominik; Roman Hennel; Bojan Smiljanov; Florian Haring; Johanna B Schaubächer; Constanze Braun; Lena Padovan; Robert Pick; Martin Canis; Christian Schulz; Matthias Mack; Ewgenija Gutjahr; Peter Sinn; Jörg Heil; Katja Steiger; Sandip M Kanse; Wilko Weichert; Markus Sperandio; Kirsten Lauber; Fritz Krombach; Christoph A Reichel
Journal:  EMBO Mol Med       Date:  2021-05-16       Impact factor: 12.137

4.  Gene expression of fibrinolytic markers in coronary thrombi.

Authors:  Jostein Nordeng; Svein Solheim; Sissel Åkra; Hossein Schandiz; Pavel Hoffmann; Borghild Roald; Bjørn Bendz; Harald Arnesen; Ragnhild Helseth; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2022-04-29

5.  Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects.

Authors:  Christoph A Reichel; Maximilian E T Hessenauer; Kerstin Pflieger; Markus Rehberg; Sandip M Kanse; Stefan Zahler; Fritz Krombach; Alexander Berghaus; Sebastian Strieth
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

6.  Therapeutic targeting of extracellular DNA improves the outcome of intestinal ischemic reperfusion injury in neonatal rats.

Authors:  Michael Boettcher; Georg Eschenburg; Stefan Mietzsch; Miguel Jiménez-Alcázar; Michaela Klinke; Deirdre Vincent; Bastian Tiemann; Robert Bergholz; Konrad Reinshagen; Tobias A Fuchs
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

7.  High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice.

Authors:  Kenny Schlosser; Mohamad Taha; Yupu Deng; Lauralyn A McIntyre; Shirley H J Mei; Duncan J Stewart
Journal:  Thorax       Date:  2017-09-25       Impact factor: 9.139

Review 8.  NF-κB and tPA Signaling in Kidney and Other Diseases.

Authors:  Samantha White; Ling Lin; Kebin Hu
Journal:  Cells       Date:  2020-05-29       Impact factor: 6.600

9.  Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1).

Authors:  Luca Liberale; Maria Bertolotto; Silvia Minetti; Paola Contini; Daniela Verzola; Pietro Ameri; Giorgio Ghigliotti; Aldo Pende; Giovanni G Camici; Federico Carbone; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

Review 10.  Coagulation and Fibrinolysis in Kidney Graft Rejection.

Authors:  Giovanni Stallone; Paola Pontrelli; Federica Rascio; Giuseppe Castellano; Loreto Gesualdo; Giuseppe Grandaliano
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.